MLICM
APYX icon

Metropolitan Life Insurance Company (MetLife)’s Apyx Medical APYX Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,177
Closed -$14.2K – 2375
2022
Q1 		$14.2K Sell
2,177
-6,649
-75% -$65.5K ﹤0.01% 2219
2021
Q4 		$113K Hold
8,826
– – ﹤0.01% 2405
2021
Q3 		$122K Buy
+8,826
New +$92.8K ﹤0.01% 2414
2021
Q2 		– Sell
-10,904
Closed -$105K – 2722
2021
Q1 		$105K Buy
+10,904
New +$109K ﹤0.01% 2406
2020
Q1 		– Sell
-12,861
Closed -$109K – 2508
2019
Q4 		$109K Hold
12,861
– – ﹤0.01% 2287
2019
Q3 		$87.1K Buy
+12,861
New +$91.3K ﹤0.01% 2369

Other funds holding APYX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
KLC
Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $9.23B AUM 27.52% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
IP
Invenire Partners Ridgefield, Connecticut $65.4M AUM 18.1% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s APYX Position: Q2 2022 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Apyx Medical (APYX) in Q2 2022, closing a stake of 2,177 shares — an estimated $14.2K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in APYX in Q3 2019 and held it in 6 quarters. The position peaked at $122K in Q3 2021. 63 funds tracked by Wall St. Rank hold APYX as of Q2 2022.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Apyx Medical position as of Q2 2022 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 2,177 Apyx Medical shares in Q2 2022, an estimated $14.2K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Apyx Medical in Q3 2019 and held it in 6 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Apyx Medical position peaked at $122K in Q3 2021.
  • 63 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2022.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2022, filed 11 Aug 2022.